Delivery Order SPE2DB22D1017-SPE2DB25FYRPB
- Not listed
- The Defense Logistics Agency awarded a $9,248.01 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used to treat systemic lupus erythematosus and other...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector, with an ultimate completion date of October 3, 2025. This non-competitive, firm fixed-price delivery order was issued on September 12, 2025, under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This firm fixed price, non-set-aside contract will be performed at the contractor's Conshohocken, Pennsylvania location with an ultimate completion date of October 7, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector, with an ultimate completion date of October 16, 2025. This non-competitive, firm fixed-price delivery order represents a single purchase of this biologic medication used primarily in the treatment of systemic lupus erythematosus. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $3,082.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with a completion date of August 21, 2025. This non-competitive award was issued to the company's corporate office located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price delivery order with no set-aside designation, placing performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a $12,330.68 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical supply. The contract, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 9, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 19, 2025, with an ultimate completion date of October 10, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded a $9,248.01 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with a completion date of September 24, 2025. This delivery order is priced on a firm fixed-price basis and was awarded competitively with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRPBDelivery Order
The Defense Logistics Agency awarded a $6,165.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector, with an ultimate completion date of October 14, 2025. This non-set-aside competitive award was issued on September 22, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this delivery order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. Benlysta is a biologic therapy used for treating systemic lupus erythematosus and other autoimmune conditions, making it part of AmerisourceBergen's comprehensive portfolio of specialty medications supplied to the Defense Health Agency and other federal healthcare systems. The award exemplifies DLA's reliance on AmerisourceBergen's prime vendor arrangement to rapidly source brand-name pharmaceuticals across multiple therapeutic domains in support of military medical readiness and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/22/25 |